Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. (PLRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
plrx · stock forecast · 16 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$3.00
Consensus
$3.00
+160.9% upside
Low
$3.00
Median: $3 · Last Close: $1.15
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.13 | ↓ 1.46% |
1-day model range: $1.12–$1.14. Peak: $1.14 (-1.46%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -31.2% |
| 2028 | — | -42.0% |
| 2029 | — | -46.5% |
| 2030 | — | -48.6% |
| 2031 | — | -49.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · PLRX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-13 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-03-12 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-11-07 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-10-10 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2025-08-08 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-03-18 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-04 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-03-04 | Citigroup | Maintains | Neutral→Neutral |
| 2025-03-04 | Needham | Downgrade ↓ | Buy→Hold |
| 2025-03-04 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Pliant Therapeutics, Inc. (PLRX) stock. Of the recent 94 rating actions, 0 were upgrades and 9 were downgrades. 16 analysts currently cover PLRX.
Analyst Recommendation Trends
PLRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 83.3% YoY
Revenue Next Year
$5M
↑ 100.0% YoY
EPS This Year
$-1.41
EPS Next Year
$-1.05
↓ 25.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast PLRX EPS of $-1.41 for the current fiscal year, based on estimates from 4 analysts. The PLRX revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PLRX stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PLRX price target is $3.00 (+160.9% upside), with an analyst consensus of Buy.
The PLRX short-term stock prediction for tomorrow is $1.13 (-1.46%). The PLRX stock prediction for 2030 projects a range of $1–$1.
Pliant Therapeutics, Inc. trades on NASDAQ under the ticker PLRX. The PLRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
PLRX forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month PLRX price target is $3.00, with a high forecast of $3.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +160.9% potential upside from the current price of $1.15.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.